Updating results

1 result for TA39 Sort: Relevance | Date

The clinical effectiveness and cost effectiveness of bupropion (Zyban) and Nicotine Replacement Therapy for smoking cessation (TA39)

This guidance has been updated and replaced by NICE guideline PH10

Technology appraisal guidance Published March 2002